Literature DB >> 19833293

Neural grafts in Huntington's disease: viability after 10 years.

Anne-Catherine Bachoud-Lévi.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19833293     DOI： 10.1016/S1474-4422(09)70278-9

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  10 in total

1.  Intrastriatal transplantation of adenovirus-generated induced pluripotent stem cells for treating neuropathological and functional deficits in a rodent model of Huntington's disease.

Authors:  Kyle D Fink; Andrew T Crane; Xavier Lévêque; Dylan J Dues; Lucas D Huffman; Allison C Moore; Darren T Story; Rachel E Dejonge; Aaron Antcliff; Phillip A Starski; Ming Lu; Laurent Lescaudron; Julien Rossignol; Gary L Dunbar
Journal:  Stem Cells Transl Med       Date:  2014-03-21       Impact factor: 6.940

Review 2.  Concise Review: Human-Animal Neurological Chimeras: Humanized Animals or Human Cells in an Animal?

Authors:  Andrew T Crane; Joseph P Voth; Francis X Shen; Walter C Low
Journal:  Stem Cells       Date:  2019-01-28       Impact factor: 6.277

3.  Restoration of the striatal circuitry: from developmental aspects toward clinical applications.

Authors:  Marie-Christin Pauly; Tobias Piroth; Máté Döbrössy; Guido Nikkhah
Journal:  Front Cell Neurosci       Date:  2012-04-19       Impact factor: 5.505

4.  Protocol for an open label: phase I trial within a cohort of foetal cell transplants in people with Huntington's disease.

Authors:  Cheney J G Drew; Feras Sharouf; Elizabeth Randell; Lucy Brookes-Howell; Kim Smallman; Bernadette Sewell; Astrid Burrell; Nigel Kirby; Laura Mills; Sophie Precious; Philip Pallmann; David Gillespie; Kerry Hood; Monica Busse; William P Gray; Anne Rosser
Journal:  Brain Commun       Date:  2021-01-19

Review 5.  Molecular Components of Store-Operated Calcium Channels in the Regulation of Neural Stem Cell Physiology, Neurogenesis, and the Pathology of Huntington's Disease.

Authors:  Ewelina Latoszek; Magdalena Czeredys
Journal:  Front Cell Dev Biol       Date:  2021-04-01

Review 6.  Cell-Based Delivery Approaches for DNA-Binding Domains to the Central Nervous System.

Authors:  Peter Deng; Julian Halmai; Jennifer J Waldo; Kyle D Fink
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

7.  Use of Genetically Altered Stem Cells for the Treatment of Huntington's Disease.

Authors:  Andrew T Crane; Julien Rossignol; Gary L Dunbar
Journal:  Brain Sci       Date:  2014-03-24

8.  Fetal striatal grafting slows motor and cognitive decline of Huntington's disease.

Authors:  Marco Paganini; Annibale Biggeri; Anna Maria Romoli; Claudia Mechi; Elena Ghelli; Valentina Berti; Silvia Pradella; Sandra Bucciantini; Dolores Catelan; Riccardo Saccardi; Letizia Lombardini; Mario Mascalchi; Luca Massacesi; Berardino Porfirio; Nicola Di Lorenzo; Gabriella Barbara Vannelli; Pasquale Gallina
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-12-17       Impact factor: 10.154

9.  Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington's Disease Mouse Models.

Authors:  Kari Pollock; Heather Dahlenburg; Haley Nelson; Kyle D Fink; Whitney Cary; Kyle Hendrix; Geralyn Annett; Audrey Torrest; Peter Deng; Joshua Gutierrez; Catherine Nacey; Karen Pepper; Stefanos Kalomoiris; Johnathon D Anderson; Jeannine McGee; William Gruenloh; Brian Fury; Gerhard Bauer; Alexandria Duffy; Theresa Tempkin; Vicki Wheelock; Jan A Nolta
Journal:  Mol Ther       Date:  2016-01-14       Impact factor: 11.454

Review 10.  Developing stem cell therapies for juvenile and adult-onset Huntington's disease.

Authors:  Kyle D Fink; Peter Deng; Audrey Torrest; Heather Stewart; Kari Pollock; William Gruenloh; Geralyn Annett; Teresa Tempkin; Vicki Wheelock; Jan A Nolta
Journal:  Regen Med       Date:  2015       Impact factor: 3.806
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.